SCHEMBL5437225

SCHEMBL5437225

CCc1nc2[nH]cnc2c(=O)n1-c1ccc(C)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.48
TP53 P04637 2/20 0.48
POLB P06746 2/20 0.43
PSMD14 O00487 1/20 0.43
RECQL P46063 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ESR1 P03372 1/20 0.39
ESR2 Q92731 1/20 0.39
ALDH1A1 P00352 5/20 0.39
MAPT P10636 3/20 0.38
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
HSP90AA1 P07900 1/20 0.38
HPGD P15428 1/20 0.38
XBP1 P17861 1/20 0.38
MAPK1 P28482 1/20 0.38
HTT P42858 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
TLR9 Q9NR96 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4559991 0.78 PDE4A (0.41) SMN1; SMN2L3MBTL1ALDH1A1HCAR1KMT2A
SCHEMBL4560224 0.76 PDE7A (0.35) L3MBTL1ALDH1A1PDE10A
SCHEMBL4559786 0.74 L3MBTL1 (0.46) POLBL3MBTL1ALDH1A1MAPTLMNA
SCHEMBL5432321 0.71 GRM5 (0.40) TP53POLBL3MBTL1GRM5
SCHEMBL3310016 0.69 HCAR1 (0.46) SMN1; SMN2MAPTRAB9ANPC1LMNA
SCHEMBL5429768 0.69 POLB (0.56) TP53POLBL3MBTL1ALDH1A1GRM5
SCHEMBL3303803 0.68 PNP (0.44) TP53POLBL3MBTL1ALDH1A1MAPT
SCHEMBL1286942 0.68 PDE4A (0.45) SMN1; SMN2TP53ALDH1A1MAPTRAB9A
Hydrochloric Acid SCHEMBL17186488 0.68 PNP (0.43) TP53POLBL3MBTL1ALDH1A1MAPT
SCHEMBL7668606 0.67 OXTR (0.35) MAPTNPC1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135454-A1 Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1) BAYLISS TRACY 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135454-A1 Bicyclic pyrimidin-4(3h)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1-receptor(vr1) TRPV1, TRPV2, TRPV4 SMN1; SMN2 3016/4885TP53 4137/4885POLB 4218/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.